First Choice Medical Inc is categorized under Blood Related Health Services in Tacoma, WA and active since 2004.
First Choice Medical Inc was established in 2004, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Blood Related Health Services business, which does work in the B2C market, and is classified as a Blood Related Health Services, under code number 621991 by the NAICS.
If you are seeking more information, feel free to contact Karan A Hibbard at the company’s single location by writing to 4902 Slayden Road Ne, Tacoma, Washington WA 98422 or by phoning (253) 927-3430. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | First Choice Medical Inc |
| Contact Person: | Karan A Hibbard |
| Address: | 4902 Slayden Road Ne, Tacoma, Washington 98422 |
| Phone Number: | (253) 927-3430 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Blood Related Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 621991 |
| Share This Business: |
First Choice Medical Inc was started in 2004 to provide professional Blood Related Health Services under the SIC code 8099 and NAICS code 621991. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Karan A Hibbard for inquiries that concern First Choice Medical Inc by calling the company number (253) 927-3430, as your correspondence is most welcome. Additionally, the physical location of the single location of First Choice Medical Inc can be found at the coordinates 47.301582,-122.430708 as well as the street address 4902 Slayden Road Ne in Tacoma, Washington 98422.
For its online presence, you may visit First Choice Medical Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.